Author(s): Thakur Abhimanyu, Kondru Sushmita, Kamilya Shruti, Kumar Amit, Goldar Epshita

Email(s): abhithakurmanyu@gmail.com

DOI: 10.5958/2231-5691.2015.00017.9   

Address: Thakur Abhimanyu1*, Kondru Sushmita2, Kamilya Shruti3, Kumar Amit1, Goldar Epshita1
1Department of Pharmaceutical Science and Technology, Birla Institute of Technology Mesra, Ranchi, India
2Executive Medical Writer, Norwich Clinical Services Pvt. Ltd., India
3Manipal College of Pharmaceutical Sciences, Karnataka, India
*Corresponding Author

Published In:   Volume - 5,      Issue - 2,     Year - 2015


ABSTRACT:
Clinical trials play a major role in the process of drug discovery. It is mandated by the Food and Drug Administration (FDA), which aids in determining the safety and efficacy of investigational product (IP) prior to its marketing for mass consumption. The clinical trial site may be a research hospital, contract research organization (CRO) or any medical institute which allow subjects to access interventions not yet accessible to the mass population. Although human research give a ray of hope for the discovery of new drug, it also resulting in litigation against all the stakeholders of clinical study. This review explores the clinical trial liability exposure of subjects, and all other concerned stakeholders and also the mitigation strategies for this exposures and the prevailing misconceptions about insurance coverage. At the same time this article presents common clinical research scenarios that pose concern for fraud and abuse and offers suggestions for various relevant amendments required to bridge the gap.


Cite this article:
Thakur Abhimanyu, Kondru Sushmita, Kamilya Shruti, Kumar Amit, Goldar Epshita. Assessment of Prevailing Insurance Policies and Regulations in Context of Clinical Research Industry. Asian J. Pharm. Res. 5(2): April-June 2015; Page 114-117. doi: 10.5958/2231-5691.2015.00017.9


Recomonded Articles:

Author(s): Hiral A. Makadia, Ami Y. Bhatt, Ramesh B. Parmar, Ms. Jalpa S. Paun, H.M. Tank

DOI:         Access: Open Access Read More

Author(s): Mohd. Yaqub Khan, Maryada Roy, Raj Kumar Rawal, Umesh Kumar Bansal

DOI: 10.5958/2231-5691.2017.00007.7         Access: Open Access Read More

Author(s): Samir K. Shah, Kruti M. Patel, Pinal M. Vaviya

DOI: 10.5958/2231-5691.2017.00014.4         Access: Open Access Read More

Author(s): Akhilesh Gupta, Swati Rawat, Prabhanshu Gupta

DOI: 10.5958/2231-5691.2018.00010.2         Access: Open Access Read More

Author(s): Kaustubh V. Gavali, Manohar D. Kengar, Kiran V. Chavan, Vaishnavi P. Anekar, Naziya I. Khan

DOI: 10.5958/2231-5691.2019.00020.0         Access: Closed Access Read More

Author(s): Ashok Thulluru, Nawaz Mahammed, C. Madhavi, K. Nandini, S. Sirisha, D. Spandana

DOI: 10.5958/2231-5691.2019.00016.9         Access: Closed Access Read More

Author(s): Sarika V. Khandbahale

DOI: 10.5958/2231-5691.2019.00021.2         Access: Closed Access Read More

Author(s): Swati Rawat, Akhilesh Gupta

DOI:         Access: Open Access Read More

Author(s): B. Babu Rao, P. Harish, Saikat Das, T. Ashwin Kumar, V. Raman Koundinya

DOI:         Access: Open Access Read More

Author(s): M. Kranthi Kumar Reddy, B. Narasimha Rao, K. Ravindra Reddy

DOI:         Access: Open Access Read More

Author(s): Rathnakumar K, Jaikumar S, Sengottuvelu S.

DOI:         Access: Open Access Read More

Author(s): Sarika S. Lokhande

DOI: 10.5958/2231-5691.2019.00015.7         Access: Closed Access Read More

Author(s): Jagdish Jadhav, Dharmendra Mundhada, Rajesh Mujoriya

DOI: 10.5958/2231-5691.2015.00019.2         Access: Open Access Read More

Author(s): Waghmare Sneha S., Kadam Trupti V., Darekar A. B., Saudagar R. B.

DOI: 10.5958/2231-5691.2015.00008.8         Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 


Recent Articles




Tags